Genetic Technologies (GENE) Short Interest Ratio & Short Volume $0.76 0.00 (0.00%) (As of 12/16/2024 ET) Add Compare Share Share Short Interest Stock AnalysisChartCompetitorsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrends Genetic Technologies Short Interest DataGenetic Technologies (GENE) has a short interest of 25,900 shares. This marks a 48.00% increase in short interest from the previous month. The short interest ratio (days to cover) is 1.6, indicating that it would take 1.6 days of the average trading volume of 42,570 shares to cover all short positions.Current Short Interest25,900 sharesPrevious Short Interest17,500 sharesChange Vs. Previous Month+48.00%Dollar Volume Sold Short$19,813.50Short Interest Ratio1.6 Days to CoverLast Record DateOctober 31, 2024Outstanding Shares4,407,000 sharesPercentage of Shares Shorted0.59%Today's Trading Volume0 sharesAverage Trading Volume42,570 sharesToday's Volume Vs. Average0% Short Selling Genetic Technologies? Sign up to receive the latest short interest report for Genetic Technologies and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartGENE Short Interest Over TimeGENE Days to Cover Over TimeGENE Percentage of Float Shorted Over Time Ad Diversified Trading InstituteGenesis leading the smart algo revolution?I’m revealing an exciting breakthrough that can help trade the markets unlike anything you’ve ever seen before… Because with my BRAND NEW smart algo you’ll always have a constant stream of alerts firing off in your back pocket to choose from. Here’s why: It does all the heavy lifting for you… automatically. Stock Ticker, Entry Price, Profit Target, Stop Loss, and even an Individual Chart!You’ll want to see what I’ve put on this page right here Genetic Technologies Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 10/31/202425,900 shares $19,813.50 +48.0%N/A1.6 $0.77 10/15/202417,500 shares $13,650.00 +8,650.0%N/A0.8 $0.78 9/30/2024200 shares $155.10 -95.4%N/A0 $0.78 9/15/20244,300 shares $3,444.30 -46.9%N/A0.1 $0.80 8/31/20248,100 shares $7,209.81 -44.5%N/A0.2 $0.89 8/15/202414,600 shares $11,995.36 +156.1%N/A0.2 $0.82 Get the Latest News and Ratings for GENE and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Genetic Technologies and its competitors with MarketBeat's FREE daily newsletter. 7/31/20245,700 shares $4,691.67 -70.9%N/A0.1 $0.82 7/15/202419,600 shares $18,032.00 -69.0%N/A0.3 $0.92 6/30/202463,200 shares $94,800.00 -17.2%N/A1 $1.50 6/15/202476,300 shares $138,866.00 -39.5%N/A1.2 $1.82 5/31/2024126,200 shares $249,876.00 +495.3%N/A2.2 $1.98 5/15/202421,200 shares $50,456.00 -16.9%N/A0.6 $2.38 4/30/202425,500 shares $59,415.00 +62.4%N/A0.8 $2.33 4/15/202415,700 shares $51,417.50 +36.5%N/A0.5 $3.28 3/31/202411,500 shares $33,235.00 -58.5%N/A0.4 $2.89 3/15/202427,700 shares $74,513.00 -53.9%N/A0.9 $2.69 2/29/202460,100 shares $129,215.00 +114.6%N/A1.9 $2.15 2/15/202428,000 shares $58,100.00 -3.8%N/A1.2 $2.08 1/31/202429,100 shares $57,909.00 +3.6%N/A1.2 $1.99 1/15/202428,100 shares $66,878.00 +19.6%N/A1.2 $2.38 12/31/202323,500 shares $56,400.00 -19.8%N/A0.9 $2.40 12/15/202329,300 shares $87,314.00 -80.2%N/A1.3 $2.98 11/30/2023147,800 shares $539,543.90 -25.4%N/A1.2 $3.65 11/15/2023198,200 shares $139,889.56 -34.2%N/A1.8 $0.71 10/31/2023301,100 shares $213,449.79 +89.7%N/A2.6 $0.71 10/15/2023158,700 shares $107,550.99 -14.0%N/A1.3 $0.68 9/30/2023184,500 shares $140,699.70 -50.0%N/A1.8 $0.76 9/15/2023368,600 shares $319,760.50 +469.7%N/A3.4 $0.87 8/31/202364,700 shares $51,760.00 +22.3%N/A1 $0.80 8/15/202352,900 shares $37,559.00 -61.8%N/A0.6 $0.71 7/31/2023138,300 shares $116,172.00 -14.7%N/A1.3 $0.84 7/15/2023162,100 shares $148,045.93 +54.1%N/A1.4 $0.91 6/30/2023105,200 shares $87,400.16 +7.6%N/A0.9 $0.83 6/15/202397,800 shares $96,333.00 -53.7%N/A0.8 $0.99 5/31/2023211,200 shares $202,287.36 +161.7%N/A1.5 $0.96 5/15/202380,700 shares $76,665.00 No ChangeN/A0.4 $0.95 10/31/202269,800 shares $83,411.00 -14.8%N/A1.5 $1.20 10/15/202281,900 shares $95,823.00 +21.7%N/A1.5 $1.17 9/30/202267,300 shares $78,599.67 -20.9%N/A1.1 $1.17 9/15/202285,100 shares $128,501.00 +66.2%N/A1.1 $1.51Healthcare Takes A Big Step Forward With The Help of A.I. (Ad)To date, we've seen baseline AI models lay the groundwork. Tools like ChatGPT are useful, but they are still simple, proof-of-concept systems. For its next act, AI is going to help save lives. Already better than humans at a number of medical tasks, AI is ramping up to completely revolutionize healthcare.Click here to learn more about the booming eHealth industry - and see which microcap will be at the 8/31/202251,200 shares $75,264.00 +16.9%N/A0.7 $1.47 8/15/202243,800 shares $72,270.00 +8.4%N/A0.6 $1.65 7/31/202240,400 shares $64,640.00 -15.0%N/A0.6 $1.60 7/15/202247,500 shares $68,875.00 -22.4%N/A0.8 $1.45 6/30/202261,200 shares $70,992.00 -13.6%N/A1.1 $1.16 6/15/202270,800 shares $80,004.00 -17.2%N/A1.4 $1.13 5/31/202285,500 shares $107,105.85 -21.2%N/A1.5 $1.25 5/15/2022108,500 shares $133,455.00 -19.6%N/A1.5 $1.23 4/30/2022134,900 shares $211,793.00 -12.8%N/A1.9 $1.57 4/15/2022154,700 shares $280,007.00 -23.4%N/A2.1 $1.81 3/31/2022202,000 shares $397,940.00 -38.2%N/A2.6 $1.97 3/15/2022326,600 shares $604,210.00 -6.9%N/A3.5 $1.85 2/28/2022350,900 shares $726,363.00 +23.5%N/A2.5 $2.07 2/15/2022284,200 shares $582,610.00 -11.2%N/A2 $2.05 1/31/2022320,200 shares $595,572.00 -0.5%N/A2.3 $1.86 1/15/2022321,700 shares $598,362.00 -4.8%N/A2.3 $1.86 12/31/2021337,900 shares $635,252.00 -14.2%N/A2.4 $1.88 12/15/2021393,800 shares $823,042.00 +17.2%N/A2.7 $2.09 11/30/2021336,100 shares $803,279.00 -2.8%N/A3.4 $2.39 11/15/2021345,700 shares $916,105.00 -9.5%N/A3.1 $2.65 10/29/2021381,800 shares $1.10 million -6.9%N/A2.8 $2.89 10/15/2021410,200 shares $1.24 million -7.8%N/A1.6 $3.02 9/30/2021444,900 shares $1.37 million -36.3%N/A1.6 $3.09 9/15/2021698,600 shares $2.34 million -13.4%N/A2.2 $3.35 8/31/2021806,700 shares $2.73 million -18.8%N/A1.7 $3.39 8/13/2021993,200 shares $3.13 million -6.3%N/A1.5 $3.15 7/30/20211,060,000 shares $3.60 million +27.6%N/A1.6 $3.40 7/15/2021830,800 shares $2.80 million -8.7%N/A1.3 $3.37 6/30/2021909,500 shares $3.87 million -18.1%N/A1.4 $4.25 6/15/20211,110,000 shares $4.50 million +5.7%N/A1.1 $4.05 5/28/20211,050,000 shares $4.32 million -9.5%N/A1.1 $4.11 5/14/20211,160,000 shares $4.18 million -4.9%N/A1.3 $3.60 4/30/20211,220,000 shares $5.08 million +6.1%N/A1.2 $4.16 4/15/20211,150,000 shares $4.70 million -4.2%N/A0 $4.09 3/31/20211,200,000 shares $4.97 million -9.8%N/A0.6 $4.14 3/15/20211,330,000 shares $6.29 million -6.3%N/A0.7 $4.73 2/26/20211,420,000 shares $6.26 million -7.2%N/A0.6 $4.41 2/12/20211,530,000 shares $7.24 million +10.9%N/A0.7 $4.73 1/29/20211,380,000 shares $6.38 million +6.2%N/A0.7 $4.62 1/15/20211,300,000 shares $5.76 million +10.2%N/A0.7 $4.43 12/31/20201,180,000 shares $4.31 million +12.4%N/A1.1 $3.65 12/15/20201,050,000 shares $3.68 million +76.3%N/A1.1 $3.50 11/30/2020595,500 shares $1.89 million +1.9%N/A0.6 $3.18 11/15/2020584,500 shares $1.75 million +7.5%N/A0.8 $3.00 10/30/2020543,500 shares $1.66 million +38.0%N/A0.7 $3.06 10/15/2020393,800 shares $1.33 million +170.5%N/A0.4 $3.39 9/30/2020145,600 shares $503,776.00 -75.5%N/A0 $3.46 9/15/2020594,500 shares $2.32 million +548.3%N/A0.1 $3.91 8/31/202091,700 shares $377,804.00 -2.7%N/A0 $4.12 8/14/202094,200 shares $367,380.00 -77.2%N/A0 $3.90Healthcare Takes A Big Step Forward With The Help of A.I. (Ad)To date, we've seen baseline AI models lay the groundwork. Tools like ChatGPT are useful, but they are still simple, proof-of-concept systems. For its next act, AI is going to help save lives. Already better than humans at a number of medical tasks, AI is ramping up to completely revolutionize healthcare.Click here to learn more about the booming eHealth industry - and see which microcap will be at the 7/31/2020413,800 shares $1.73 million +2,877.0%N/A0.1 $4.17 7/15/202013,900 shares $31,414.00 -82.6%N/A0 $2.26 6/30/202080,000 shares $182,400.00 +8.1%N/A0.1 $2.28 6/15/202074,000 shares $157,620.00 +197.2%N/A0.1 $2.13 5/29/202024,900 shares $50,796.00 +14.8%N/A0 $2.04 5/15/202021,700 shares $52,948.00 -42.0%N/A0 $2.44 4/30/202037,400 shares $71,808.00 +47.8%N/A0.1 $1.92 4/15/202025,300 shares $42,784.83 -26.5%N/A0 $1.69 3/31/202034,400 shares $62,608.00 -72.1%N/A0.1 $1.82 3/13/2020123,300 shares $208,377.00 -41.3%N/A3.7 $1.69 2/28/2020210,000 shares $308,700.00 -3.6%N/A0.4 $1.47 2/14/2020217,900 shares $562,182.00 -25.2%N/A0.4 $2.58 1/31/2020291,200 shares $937,664.00 -52.3%N/A0.5 $3.22 1/15/2020609,900 shares $2.25 million +431.7%N/A1.1 $3.69 12/31/2019114,700 shares $496,651.00 +431.0%N/A0.2 $4.33 GENE Short Interest - Frequently Asked Questions What is Genetic Technologies' current short interest? Short interest is the volume of Genetic Technologies shares that have been sold short but have not yet been closed out or covered. As of October 31st, traders have sold 25,900 shares of GENE short. Learn More on Genetic Technologies' current short interest. What is a good short interest ratio for Genetic Technologies? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. GENE shares currently have a short interest ratio of 2.0. Learn More on Genetic Technologies's short interest ratio. Is Genetic Technologies' short interest increasing or decreasing? Genetic Technologies saw a increase in short interest in the month of October. As of October 31st, there was short interest totaling 25,900 shares, an increase of 48.0% from the previous total of 17,500 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Genetic Technologies' short interest compare to its competitors? Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Genetic Technologies: HCW Biologics Inc. (0.65%), NRx Pharmaceuticals, Inc. (6.36%), Relmada Therapeutics, Inc. (3.51%), Sol-Gel Technologies Ltd. (0.70%), Kazia Therapeutics Limited (0.51%), Acurx Pharmaceuticals, Inc. (3.22%), Aspira Women's Health Inc. (4.33%), PharmaCyte Biotech, Inc. (0.75%), ImmunoPrecise Antibodies Ltd. (1.30%), Imunon, Inc. (5.36%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.08 billion), AppLovin Co. ($3.18 billion), Paychex, Inc. ($2.64 billion), Nu Holdings Ltd. ($2.54 billion), International Paper ($2.46 billion), Cencora, Inc. ($2.27 billion), Moderna, Inc. ($1.87 billion), SoFi Technologies, Inc. ($1.81 billion), Lululemon Athletica Inc. ($1.75 billion), and Onsemi ($1.71 billion). View all of the most shorted stocks. What does it mean to sell short Genetic Technologies stock? Short selling GENE is an investing strategy that aims to generate trading profit from Genetic Technologies as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Genetic Technologies? A short squeeze for Genetic Technologies occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of GENE, which in turn drives the price of the stock up even further. How often is Genetic Technologies' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including GENE, twice per month. The most recent reporting period available is October, 31 2024. More Short Interest Resources from MarketBeat Related Companies HCW Biologics Short Interest NRx Pharmaceuticals Short Interest Relmada Therapeutics Short Interest Sol-Gel Technologies Short Interest Kazia Therapeutics Short Interest Acurx Pharmaceuticals Short Interest Aspira Women's Health Short Interest PharmaCyte Biotech Short Interest ImmunoPrecise Antibodies Short Interest Imunon Short Interest Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:GENE) was last updated on 12/18/2024 by MarketBeat.com Staff From Our PartnersThis drone stock is setting up to transform medical supply deliveryDrone stocks are on a tear, with certain symbols seeing gains as high as 300% over just a matter of weeks.The Tomorrow Investor | SponsoredUncover the Top Gold Stock of the Bull MarketGold Stocks Are Surging—Is West Red Lake Gold Mines Your Next Profit Play?Huge Alerts | SponsoredHealthcare Takes A Big Step Forward With The Help of A.I.To date, we've seen baseline AI models lay the groundwork. Tools like ChatGPT are useful, but they are still s...Wall Street Star | SponsoredSeeing is believing… Today, I want to share all the details with you… and show you how to leverage this incredible wealth-building ...Porter & Company | SponsoredPlease don’t take this warning lightly…Something huge is about to hit the stock market. Wall St. legend Louis Navellier calls it: "The most signif...InvestorPlace | SponsoredWe recommended Palantir in 2021, now we’re recommending this...My research indicates there is only one investment that can meet AI's unprecedented demand for energy.Behind the Markets | SponsoredMissed Nvidia? Buy Elon Musk’s “Silent Partner”In February 2016, when almost nobody was talking about artificial intelligence… I picked Nvidia as one of my f...Brownstone Research | Sponsored50-year Wall Street legend: “Sell this tech stock NOW”Something very strange is happening to U.S. stocks following President Trump's victory... And this could s...Chaikin Analytics | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Genetic Technologies Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Genetic Technologies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free GENE Stock Alerts